AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2005
Jul 6, 2005
30339_dirs_2005-07-06_496f1da6-a66c-433d-80db-10a600e630ed.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2005-07-01
Reporting Person: GAILEY JOHN R (VP, Gen. Counsel & Sec.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-07-01 | Common Stock | A | 10.2662 | $28.1 | Acquired | 1760.6434 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 42246.3222 | Direct |
| Common Stock | 194.0831 | Indirect |
Footnotes
F1: Reflects additional shares purchased through divided reinvestments based on most recent plan statement.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27